GATIFLOXACINE

Gatifloxacin is a fluoroquinolone antibiotic inhibiting bacterial DNA gyrase. Side effects include dysglycemia, tendon inflammation, and GI disturbances.

SKU: 9246d62895b3 Category: Tag:

Product Description


Mechanism of Action

Gatifloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication and chromosomal segregation.

Benefits and Advantages

Used in quinolone-resistance modelling, gyrase-inhibition assays, DNA-replication pathway studies and Gram-positive/negative research.

Side Effects and Risks

Risk of QT prolongation, dysglycemia, tendon toxicity and CNS effects. Handle with fluoroquinolone-class precautions.

Datasheet


Molecular Formula

C19H22FN3O4

Molecular Weight

375.4 g/mol

CAS Number

112811-59-3

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

Gatifloxacin; 112811-59-3; Tequin; Gatiflo; Zymar

IUPAC/Chemical Name

1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid

InChl Key

XUBOMFCQGDBHNK-UHFFFAOYSA-N

InChl Code

InChI=1S/C19H22FN3O4/c1-10-8-22(6-5-21-10)16-14(20)7-12-15(18(16)27-2)23(11-3-4-11)9-13(17(12)24)19(25)26/h7,9-11,21H,3-6,8H2,1-2H3,(H,25,26)

References

https://pubchem.ncbi.nlm.nih.gov/compound/5379;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download